相关实验视频

Updated: Jan 9, 2026

Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes

Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes

Published on: March 3, 2023

对多西环林暴露后预防的审查及其对抗菌素耐药性及其对人类微生物群的影响

Ruben Fernandez-Ibanez¹, Santiago Moreno², Moises Fernandez³

¹Infectious Diseases Department, University Hospital Ramón y Cajal, IRYCIS, Alcalá University, Ctra de Colmenar, km 9, 100, 28034, Madrid, Spain. rubenfernaniba@gmail.com.

Infectious diseases and therapy

|December 9, 2025

概括

多西环素暴露后预防 (DoxyPEP) 有效地减少了克拉米迪亚和梅毒,但可能会增加淋病耐药性. 仔细监测抗菌素耐药性对于安全使用DoxyPEP至关重要.

科学领域:

传染性疾病传染性疾病
抗微生物耐药性抗微生物耐药性
公共卫生公共卫生

背景情况:

性传播感染 (STIs) 构成一个重大的全球健康挑战,尼塞利亚淋病,克拉米迪亚甲状腺炎和Treponema pallidum的发病率越来越高.
杜西环素暴露后预防 (DoxyPEP) 是一种新的干预措施,在没有避孕套的性行为后使用单剂量杜西环素来预防性传播感染.

研究的目的:

评估DoxyPEP对STI发病率和抗菌素耐药性模式的疗效和影响.
评估DoxyPEP对更广泛的人类微生物组抗体的影响.

主要方法:

对来自旧金山和金县的随机对照试验和监视数据的审查.
基因组分析以确定耐药性机制和潜在的耐药性共同选择.
评估DoxyPEP对人类微生物群的功能抗体的影响.

主要成果:

DoxyPEP显示出对克拉米迪亚和梅毒的持续有效性.
对淋病的保护是可变的,受基线抗性和解剖部位的影响.
高频度的DoxyPEP使用与球菌对四环素耐药性增加相关.
DoxyPEP改变了微生物组的抗性,放大了四环素耐药性基因表达,并选择了耐药细菌.

结论:

DoxyPEP对控制克拉米迪亚和梅毒有好处,并在低阻力环境中提供对淋病的有条件保护.
部署DoxyPEP需要抗菌管理,局部耐药性数据和增强的基因组监测,以减轻人口层面的风险.
分子监测对于监测DoxyPEP使用后的耐药性溢出至关重要.

关键词:

尼塞里亚淋病菌 (Neisseria gonorrhoeae) 是一种传染病.抗微生物耐药性抗微生物耐药性在多克西环林暴露后的预防.微生物组是一个微生物组.公共卫生监督是对公共卫生的监督.抵抗力抵抗力抵抗力性传播感染性传播感染.

更多相关视频

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

相关概念视频

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

Development of Antibiotic Resistance

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...

Antimicrobial Effectiveness

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...

Pharmacovigilance

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...

Infection

Infection

When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...

Desensitization and Tachyphylaxis

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.